Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic ...
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
Surprising Breast Cancer Risk Factors
Breast cancer was never on my radar. After all, I learned long ago that I don't have the BRCA1 or 2 gene mutations, and I have no family history of the disease. So, for most of my adult life I took ...
Hundreds found to have higher risk of cancer after genetic screening
The NHS in England has initiated a genetic testing programme that has had a remarkable uptake in its first year ...
The Power of Personalized Breast Cancer Care
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Four in 10 Ashkenazi Jews have cancer-causing gene mutation
The mutation is found in four out of 10 people with Ashkenazi Jewish ancestry. Out of the 11,000 people tested during the new ...
Hundreds of people found to have higher risk of cancer
Now new data from the programme, shared with the PA news agency, show that 235 people have been identified as having a higher ...
Hundreds of people at increased cancer risk identified by new NHS BRCA testing programme
The NHS in England initiated a genetic testing programme for people with Jewish backgrounds, as part of the screening ...
Hundreds of people with Jewish ancestry found to have BRCA gene mutation
Hundreds of people with Jewish ancestry have been identified as having a mutation of the BRCA gene which puts them at a ...
Rolling Out1 天
Why prostate cancer is a major challenge in modern oncology
Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...
The Nolans' tragic cancer curse as Linda becomes third to die from disease
Linda Nolan has become the third of the four Nolan sisters to have died from cancer disease in the past two years ...